Martin Edwards

Insider Reports History

Entity
Individual
Location
15 New England Executive Park, Burlington, MA
Signature
/s/ Robert Farrell, Attorney-in-Fact for Martin Edwards
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Edwards:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc Director Ordinary Shares 145K $2.9M $20.00 Nov 20, 2023 Direct
Morphic Holding, Inc. Director Common Stock 0 $0 $55.79 Aug 16, 2024 Direct
Verona Pharma plc Director Share Options (Right to Buy) 240K Apr 29, 2024 Direct
Inozyme Pharma, Inc. Director Stock Option (right to buy) 28K Jun 18, 2024 Direct
KalVista Pharmaceuticals, Inc. Director Director Stock Option (Right to Buy) 10K Sep 30, 2021 Direct
Morphic Holding, Inc. Director Stock Option (Right to Buy) 0 Aug 16, 2024 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by Martin Edwards

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MORF Morphic Holding, Inc. Aug 16, 2024 6 $0 4 Aug 21, 2024 Director
INZY Inozyme Pharma, Inc. Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
MORF Morphic Holding, Inc. Jun 4, 2024 1 $0 4 Jun 5, 2024 Director
VRNA Verona Pharma plc Apr 29, 2024 1 $0 4 Apr 30, 2024 Director
VRNA Verona Pharma plc Nov 20, 2023 1 $62K 4 Nov 22, 2023 Director
MORF Morphic Holding, Inc. Nov 13, 2023 1 $48.8K 4 Nov 15, 2023 Director
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 9 $0 4 Sep 26, 2023 Director
INZY Inozyme Pharma, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 4 $182K 4 Jun 9, 2023 Director
MORF Morphic Holding, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
INZY Inozyme Pharma, Inc. Jun 10, 2022 1 $0 4 Jun 14, 2022 Director
MORF Morphic Holding, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
RETA REATA PHARMACEUTICALS INC Jun 8, 2022 4 $160K 4 Jun 9, 2022 Director
VRNA Verona Pharma plc Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
RETA REATA PHARMACEUTICALS INC Jan 3, 2022 2 $3.21K 4 Jan 5, 2022 Director
KALV KalVista Pharmaceuticals, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 Director
VRNA Verona Pharma plc Aug 9, 2021 1 $0 4 Aug 10, 2021 Director
INZY Inozyme Pharma, Inc. Jun 23, 2021 1 $0 4 Jun 24, 2021 Director
MORF Morphic Holding, Inc. Jun 16, 2021 1 $0 4/A Apr 29, 2022 Director
RETA REATA PHARMACEUTICALS INC Jun 10, 2021 1 $0 4 Jun 14, 2021 Director